These findings are consistent with the results of this study, which suggest that moxibustion therapy for RA can decrease TNF-α and IL-1β by increasing the levels of β-EP and Dyn in the body, thus playing an anti-inflammatory and analgesic role. This evidence concerns the gene TNF and rheumatoid arthritis.